Search
Filters
Clear All
  • 15
  • 52
  • 2
  • 647

Phase

  • 1
  • 11
  • 14
  • 47
  • 7
  • 66
  • 6
  • 541
  • 654
  • 299

Found 716 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A First-in-Human Phase I Trial to Determine the Safety and the Pharmacokinetic Profile of DSP-0337 in Patients With Advanced Solid Tumors

G
Greg Durm, MD
18-100 years
All genders
This is a Phase 1, open label, multi-center study of orally administered DSP-0337 in adult subjects with advance solid tumors that are refractory to standard treatment, or for whom no effective therapy exists.
Learn More

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

S
Sandeep Batra, MD
1-30 years
All genders
The purpose of this study is to look at iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma.
Learn More

Online activities among transgender community

N
Nathan Ensmenger
13-100 years
All genders
The purpose of this study is to observe how transgender people in the United States use online spaces and to provide analysis of how trans people create their own knowledge about intersectional relations of gender through their speech and practices on the Internet.
Learn More

Cardiac Vagal Effects of Gastric Electrical Stimulation and Vagal Nerve Action Potentials in Vagus nerve in Patients with Gastroparesis- Randomized Phase

T
Thomas Nowak, MD
18-100 years
All genders
The purpose of this study is to assess if the Gastric Electric Stimulator (GES) device may influence the vagal output, which helps in the relief of the symptoms of gastroparesis, mainly nausea and vomiting.
Learn More

The effects of vision on postural sway and H-reflex

D
David Koceja, PhD
18-70 years
All genders
The purpose of this study is to explore the role vision plays in maintaining posture and muscular activity while standing.
Learn More

"Understanding facial morphology: Computational extraction of facial soft tissue thickness from CBCT scan"

S
Susan Walsh
18-100 years
All genders
We are working on a study that would investigate on the genetics behind differences in facial morphology (form and structure of facial features).
Learn More

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

S
Sandeep Batra, MD
30 years and younger
All genders
This trial studies how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or liver cancer after surgery.
Learn More

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects With High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel Genomic Biomarker DGM1?

M
Michael Robertson, MD
18-100 years
All genders
The purpose of this study is to compare the effect of RCHOP/enzastaurin versus R-CHOP on overall survival (OS) in treatment-naive, high-risk subjects with Diffuse Large B-Cell Lymphoma (DLBCL) who possess the DGM1 biomarker.
Learn More

A Phase 2 Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients With Metastatic Melanoma

T
Theodore Logan, MD
18-70 years
All genders
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) with Lifileucel infusion (LN-144) followed by interleukin 2 (IL-2) after a nonmyeloablative lymphodepletion (NMA-LD) preparative regimen.
Learn More

Phase II open-label global study to evaluate the effect of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive Low Grade Glioma (LGG) or relapsed or refractory High Grade Glioma (HGG)

M
Michael Ferguson, MD
1-17 years
All genders
The purpose of this study is to investigate the activity of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive low grade glioma or relapsed or refractory high grade glioma.
Learn More
441 - 450 of 716